## Abstract ## BACKGROUND The objective of this study was to determine whether HERβ2 overexpression is associated with improved response to neoadjuvant chemotherapy with 5βfluorouracil, doxorubicin, cyclophosphamide (FAC) in patients with breast carcinoma. ## METHODS Ninetyβseven patients with S
HER-2/neu expression as a predictor of response to neoadjuvant docetaxel in patients with operable breast carcinoma
β Scribed by Peter A. Learn; I-Tien Yeh; Michelle McNutt; Gary B. Chisholm; Brad H. Pollock; Dennis L. Rousseau Jr.; Frances E. Sharkey; Anatolio B. Cruz; Morton S. Kahlenberg
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 156 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##
## Abstract ## BACKGROUND The objective of the current study was to determine whether __herβ2__ amplification was associated with a pathologic response to preoperative chemotherapy with taxanes in patients with earlyβstage breast carcinoma. ## METHODS The authors evaluated 71 patients treated fo